GH1 and metabolic syndrome: CRCI arises from the cancer itself or its treatments and is further exacerbated by factors such as age, genetics, and psychological well-being.2 Beyond cognition, treatments disrupt metabolic processes, influencing weight regulation, appetite homeostasis and energy regulation, dyslipidemia, growth hormone regulation, and cardiovascular health.